Ovarian cancer experts and patients from Cambridge and Birmingham have developed clear, accessible information in multiple languages about the benefits of genetic testing for ovarian cancer patients.
A cancer drug currently in the final stages of clinical trials could offer hope for the treatment of a wide range of inflammatory diseases, including gout, heart failure, cardiomyopathy, and atrial fibrillation, say Cambridge scientists.
We are immensely grateful to Ely City Golf Club Ladies’ teams for raising £8,500 to support our research in ovarian cancer at the Cancer Research UK Cambridge Centre.
Seven (including two in the Black Leaders in Cancer initiative) four-year MRes + PhD studentships and five Clinical Research Training Fellowships are available, starting in October 2024.